|
Mirabegron Clinical Trials
3 actively recruiting trials across 2 locations
Also known as: Myrbetriq
Pipeline
Phase 1: 1Phase 2: 2
Top Sponsors
- Zhejiang Provincial People's Hospital1
- Philip Kern1
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
Indications
- Cancer2
- PreDiabetes1
- DLBCL - Diffuse Large B Cell Lymphoma1
- Diabetes1
- SCLC1
Other1 trial
Lexington, Kentucky1 trial
Mechanisms for Activation of Beige Adipose Tissue in Humans
University of Kentucky
Phase 2
Bethesda, Maryland1 trial
The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists
National Institutes of Health Clinical Center
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.